Acute Porphyria Drugs

Monograph

N06BC01 - Caffeine
Propably not porphyrinogenic
PNP

Rationale
Metabolised by CYP 1A2. Widely used as beverage but no reports of porphyrinogenic effects. One reference:
Chemical description
Xantine derivative used as a stimulant and headache analgesic. Metabolized by CYP1A2. Inhibitor of CYP 1A2.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes N06B / N06BC or go back.
References
Tradenames

Gencebok · Peyona Cafeine · Gencebok · Peyona Durvitan · Gencebok · Peyona Gencebok · Peyona · Tabletta Coffeini Gencebok · Peyona Peyona Caffeine citrate · Fenapin · Gencebok · Peyona · Pro Plus Gencebok · Peyona Caffeine · Gencebok · Koffein · Peyona Coffeini citras · Gencebok · Kofeiny · Peyona Peyona Gencebok · Peyona Gencebok · Peyona Gencebok · Peyona Gencebok · Peyona Peyona Gencebok · Kofeinijev citrat · Peyona Gencebok · Peyona
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙